#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fallopian tube cancer Hyperinsulinaemic hypoglycaemia Metastases to central nervous system Non-small cell lung cancer metastatic Fms-like tyrosine kinase 3 positive Biotinidase deficiency Breast angiosarcoma Anal squamous cell carcinoma Immunoglobulin G4 related disease Leukoencephalopathy Neuromyelitis optica spectrum disorder Nephropathy Ataxia telangiectasia Myelodysplastic syndrome B-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease Focal segmental glomerulosclerosis – Basic Information Adrenogenital syndrome – Diagnostics Myelodysplastic syndrome – Treatment Inclusion body myositis – Treatment Glycogen storage disease type I Mucopolysaccharidosis III – Trials in Disease Aicardi-Goutieres syndrome Noonan syndrome – Basic Information Leiomyosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bulevirtide Enalapril Maleate Lauromacrogol 400 Dexmedetomidine Hydrochloride Ifezuntirgene Inilparvovec Methohexital Sodium Bleomycin Sulfate Tenofovir Alafenamide Narsoplimab TAGRAXOFUSP Apremilast Bosentan Gs-1427 Aflibercept Phleum Pratense Pollen Extract Indacaterol Acetate Mbs2320 Proline AZD5148 L-Histidine Hydrochloride More therapies…

    Learn about Your Condition

    Pigmentary glaucoma Rectal cancer stage III Coronary artery occlusion Pleural mesothelioma Oxygen saturation Thrombocytosis Alcoholism Cytokine release syndrome Aortic valve disease Marginal zone lymphoma Ocular myasthenia Juvenile spondyloarthritis Acne Ewing's sarcoma Alexander disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Propranolol Treatment for Brain Hemangioblastomas in Patients with Von Hippel-Lindau Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Von Hippel-Lindau disease
    Investigated Drugs:
    • Propranolol
    France

  • A study of 5-aminolevulinic acid with radiotherapy (radiodynamic therapy) for patients with first recurrence of glioblastoma brain tumor

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany

  • Study on the Effectiveness of Durvalumab for Patients with Metastatic Breast Cancer in Early Chemotherapy Stages

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Acetylsalicylic Acid (Aspirin) 150 mg for Prevention of Complications in Pregnant Women with Chronic Hypertension

    Recruiting

    3 1 1
    Investigated Diseases:
    • Foetal growth restriction
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Emtansine
    • Pertuzumab
    • Trastuzumab
    France

  • Study of Amiloride tablets for prevention of migraine with aura attacks

    Recruiting

    4 1 1
    Investigated Diseases:
    • Migraine with aura
    Investigated Drugs:
    • Amiloride Hydrochloride Dihydrate
    France
Previous Page
1 … 615 616 617 618 619 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!